ADVFN Logo ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Registrieren

Bereits Mitglied? Einloggen

Pepperstone

Jetzt Handeln

Pepperstone
Marktdaten
News
Werkzeuge
Märkte
Entdecken

Hot Features

Follow Feed

Vernetzen Sie sich mit Händlern und Investoren in unserer Follow-Feed-Community.

Optionen-Flow

Erkunden Sie umfassende Optionsdaten und nutzen Sie erweiterte Filter mit Options Flow.

Watchlist

Organisieren und überwachen Sie Ihre Aktien- und Vermögensbeobachtungsliste mit dem Monitor.
Anmelden Premium IconPremium Help Menu
DAX
18.704,42
-0,11%
S&P 500
5.303,27
0,12%
Dow Jones
40.003,59
0,34%
Euro vs US Dollar
1,08945
-0,01%
Bitcoin
66.907,72
-0,26%
Registration Strip Icon for alerts Registrieren Sie sich für Echtzeit-Benachrichtigungen, benutzerdefinierte Portfolios und Marktbewegungen.
Registrieren
  1. Startseite
  2. Investieren
  3. Aktien
  4. USA
  5. NASDAQ
  6. Novus Therapeutics Inc (NVUS)

  7. Novus Therapeutics Inc (NVUS) News

NVUS

Novus Therapeutics (NVUS)

Novus Therapeutics Inc
Von:
Sortieren nach:
 Showing the most relevant articles for your search:NASDAQ:NVUS
DatumZeitQuelleÜberschriftSymbolFirma
22/06/202312h02Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:NVUSNovus Therapeutics Inc
08/06/202322h05Edgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(3) (424b3)NASDAQ:NVUSNovus Therapeutics Inc
05/06/202312h04Edgar (US Regulatory)Notice of Effectiveness (effect)NASDAQ:NVUSNovus Therapeutics Inc
22/05/202319h27Edgar (US Regulatory)Small Company Offering and Sale of Securities Without Registration (d)NASDAQ:NVUSNovus Therapeutics Inc
18/05/202323h16Edgar (US Regulatory)Securities Registration Statement (simplified Form) (s-3)NASDAQ:NVUSNovus Therapeutics Inc
11/05/202323h07Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:NVUSNovus Therapeutics Inc
11/05/202322h04Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:NVUSNovus Therapeutics Inc
03/05/202300h49Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:NVUSNovus Therapeutics Inc
03/05/202300h49Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:NVUSNovus Therapeutics Inc
03/05/202300h48Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:NVUSNovus Therapeutics Inc
03/05/202300h46Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:NVUSNovus Therapeutics Inc
03/05/202300h44Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:NVUSNovus Therapeutics Inc
03/05/202300h43Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:NVUSNovus Therapeutics Inc
01/05/202322h53Edgar (US Regulatory)Proxy Statement (definitive) (def 14a)NASDAQ:NVUSNovus Therapeutics Inc
01/05/202322h49Edgar (US Regulatory)Additional Proxy Soliciting Materials (definitive) (defa14a)NASDAQ:NVUSNovus Therapeutics Inc
01/05/202313h28Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:NVUSNovus Therapeutics Inc
30/03/202322h05Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:NVUSNovus Therapeutics Inc
03/02/202300h12Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:NVUSNovus Therapeutics Inc
03/02/202300h10Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:NVUSNovus Therapeutics Inc
03/02/202300h09Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:NVUSNovus Therapeutics Inc
03/02/202300h08Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:NVUSNovus Therapeutics Inc
03/02/202300h05Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:NVUSNovus Therapeutics Inc
02/02/202323h59Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:NVUSNovus Therapeutics Inc
02/02/202323h45Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:NVUSNovus Therapeutics Inc
02/02/202323h41Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:NVUSNovus Therapeutics Inc
23/11/202222h07Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:NVUSNovus Therapeutics Inc
14/11/202223h41Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:NVUSNovus Therapeutics Inc
14/11/202222h09Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:NVUSNovus Therapeutics Inc
11/08/202223h03Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:NVUSNovus Therapeutics Inc
11/08/202222h08Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:NVUSNovus Therapeutics Inc
 Showing the most relevant articles for your search:NASDAQ:NVUS

Kürzlich von Ihnen besucht

LSE
GRPH
TG
CLIQ
Cliq Digital
EU
CS
Axa
TG
EBA
Ebay
NYSE
SCI
Service
NYSE
BLDR
Builders FirstSource
NYSE
LOW
Lowes Companies
NYSE
LL
LL Flooring
AMEX
THV
Thermoview
TG
DR0
Deutsche Rohstoff
EU
AGN
Aegon
EU
BCP
Banco Comercial Portugues
Delayed Upgrade Clock
ADVFN Logo

Deutschland
Unternehmen
Geschäft
Popular
App herunterladen

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen

© 2024 ADVFN PLC - Alle Rechte vorbehalten